PubRank

Immunotherapy With Racotumomab in Advanced Lung Cancer

Clinical Trial ID NCT01460472

PubWeight™ 13.66‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01460472

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antibodies to watch in 2015. MAbs 2015 1.28
2 Molecular pathways and therapeutic targets in lung cancer. Oncotarget 2014 1.16
3 Involvement of a non-human sialic Acid in human cancer. Front Oncol 2014 1.06
4 Novel antibodies targeting immune regulatory checkpoints for cancer therapy. Br J Clin Pharmacol 2013 0.94
5 Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements. Front Oncol 2012 0.91
6 Immunotherapy prospects in the treatment of lung cancer and mesothelioma. Transl Lung Cancer Res 2014 0.85
7 Cross-sectional and longitudinal analysis of cancer vaccination trials registered on the US Clinical Trials Database demonstrates paucity of immunological trial endpoints and decline in registration since 2008. Drug Des Devel Ther 2014 0.82
8 Cellular and molecular immunology of lung cancer: therapeutic implications. Expert Rev Clin Immunol 2014 0.79
9 Cancer stem cells and immunoresistance: clinical implications and solutions. Transl Lung Cancer Res 2015 0.79
10 Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions. J Int AIDS Soc 2015 0.78
11 Corrigendum: involvement of a non-human sialic Acid in human cancer. Front Oncol 2014 0.75
12 Implications of Repealing the Cuban Embargo for US Medicine and Public Health. Am J Public Health 2015 0.75
13 Cancer cell associated glycans as targets for immunotherapy. Oncoimmunology 2015 0.75
14 Challenges and opportunities for cancer vaccines in the current NSCLC clinical scenario. Curr Top Med Chem 2013 0.75
15 Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3. Front Immunol 2013 0.75
16 Immunotherapy treatments for small-cell lung cancer: past, present and future. Lung Cancer Manag 2015 0.75
Next 100